ALCOHOL WITHDRAWAL-INDUCED CHANGE IN LIPOPROTEIN(A) - ASSOCIATION WITH THE GROWTH HORMONE INSULIN-LIKE GROWTH-FACTOR-I (IGF-I)/IGF-BINDING PROTEIN-1 (IGFBP-1) AXIS/
M. Paassilta et al., ALCOHOL WITHDRAWAL-INDUCED CHANGE IN LIPOPROTEIN(A) - ASSOCIATION WITH THE GROWTH HORMONE INSULIN-LIKE GROWTH-FACTOR-I (IGF-I)/IGF-BINDING PROTEIN-1 (IGFBP-1) AXIS/, Arteriosclerosis, thrombosis, and vascular biology, 18(4), 1998, pp. 650-654
Lipoprotein(a) [Lp(a)] is an important risk factor for cardiovascular
disease. Alcohol is one of the few nongenetic factors that lower Lp(a)
levels, but the metabolic mechanisms of this action are unknown. Alco
hol inhibits the growth hormone (GH)/insulin-like growth factor-I (IGF
-I) axis. Alcohol might also affect IGF-binding protein-1 (IGFBP-1), w
hich is an acute inhibitor of IGF-I. We studied how alcohol withdrawal
affects Lp(a) levels and the GH/IGF-I/IGFBP-1 axis. Male alcohol abus
ers (n=27; 20 to 64 years old) were monitored immediately after alcoho
l withdrawal for 4 days. Twenty-six healthy men, mainly moderate drink
ers, served as control subjects. Fasting blood samples were drawn to d
etermine Lp(a), IGF-I, and IGFBP-1 (by ELISA, RIA, and immunoenzymomet
ric assay, respectively). Nocturnal (12 hours) urine collection was pe
rformed in 9 alcoholics and 11 control subjects for GH analyses (RIA).
The groups were similar in age and body mass index. Lp(a), GH, and IG
F-I tended to be lower and IGFBP-1 higher in the alcoholics immediatel
y after alcohol withdrawal than in the control subjects. During the 4-
day observation in alcoholics, Lp(a) levels increased by 64% and IGF-I
levels by 41%, whereas IGFBP-1 levels decreased by 59% (P<.001 after
ANOVA for all comparisons). Urinary GH levels tended to decline. The i
ncrease in Lp(a) correlated inversely with the changes in IGFBP-1 (r=-
.63, P<.001, n=27) and GH (r=-.70, P<.05, n=9), but not with IGF-I. In
multiple regression analysis, the main predictors for the increase in
Lp(a) were IGFBP-1 and urinary GH. In conclusion, alcohol withdrawal
induces interrelated and potentially atherogenic changes in Lp(a) and
IGFBP-1 levels.